Since there was little prior information about USP53 related to neurodevelopment or psychiatric disease, preliminary immunolocalization and immunoprecipitation studies were conducted to determine whether the variant was at all consistent with the above hypothesis. The gene discussed is USP53; the disease is psychiatric disorder.